FDAAI& Medical Products Paper advocates for a tailoredrisk-based regulatory framework
JD Supra...AI are reminded to take time now to understand and prepare for FDA'srisk-based regulatory approach for AI management across the product's lifecycle …
Read the original at JDSupra ↗
- Topics
- Regulation & PolicyHealthcareGovernance & Risk Management
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”
Same story, other outlets
- FDAAI& Medical Products Paper advocates for a tailoredrisk-based regulatory framework lexology.com · Apr 03, 2024